Journal article
Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
Abstract
BACKGROUND: Cancer increases the risk of thromboembolic events, especially in people receiving anticoagulation treatments.
OBJECTIVES: To compare the efficacy and safety of low molecular weight heparins (LMWHs), direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) for the long-term treatment of venous thromboembolism (VTE) in people with cancer.
Authors
Kahale LA; Hakoum MB; Tsolakian IG; Alturki F; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H
Journal
Cochrane Database of Systematic Reviews, Vol. 2023, No. 6,
Publisher
Wiley
DOI
10.1002/14651858.cd006650.pub5
ISSN
1361-6137